- Context
- Brand, medical affairs, and market access teams are discovering that AI answer engines describe their products to patients and prescribers, and that nobody on the team knows what those answers say.
- What Brian did
- Engagements that assess how AI answer engines represent a brand and lay out the content, structured data, and source strategy to improve it. Delivered as annotated consultant reports with actions ranked by what matters in a regulated environment, and taken forward into PharmAiVA as a repeatable product.
- What to look at
- The PharmAiVA sample report shows the full deliverable for a fictional product.
Product and implementation work, with the artifacts.
Each entry follows the same shape: the situation, what Brian did, and what you can look at. Client engagements are described without naming the client.
- Context
- Field teams want to use AI for pre-call planning, account prioritization, and follow-up, and compliance teams want to know that company data and promotional rules are protected while they do it.
- What Brian did
- Wrote a universal, non-proprietary framework for how field teams can use AI across the territory-management cycle without exposing company data or violating compliance rules. Published under PharmAlliance AI Solutions.
- What to look at
- The framework document. Ask for it through the contact page.
- Context
- Beginners who aren't technical (students, parents, coaches, volunteers) and want to use AI in everyday life.
- What Brian did
- Built a self-paced, plain-language online course for beginners: a no-jargon, no-hype course that takes everyday people from “what is AI?” to AI Native in 15 practical chapters, with quizzes, hands-on labs, and pages kept current as the tools change. It includes a progress dashboard. An “Always up to date” section has three pages (Meet the Current Models, What’s New This Month, and Real People, Real Uses), with content refreshed monthly and reviewed quarterly.
- What to look at
- The course itself, at ai-native-curriculum.app.
- Context
- Oncology and biosimilar products live or die on reimbursement: coverage, coding, payment, and the evidence payers need to say yes.
- What Brian did
- Strategy and reimbursement work for oncology and biosimilar products inside Johnson & Johnson's market access organization, including Project Blue, a J&J and IBM Watson initiative on real-time glucose monitoring.
- What to look at
- The experience page places this work on the timeline. Details are available in conversation.
- Context
- Public safety and commercial drone operators lose flights to propeller icing in exactly the conditions when they are needed most.
- What Brian did
- Took a propeller anti-ice treatment from concept toward commercialization through DFG Solutions LLC. The product grew out of public safety UAS work as an FAA Part 107 remote pilot with the New Hope Eagle Fire Company.
- What to look at
- PropClear PRO product information is available on request through the contact page.